Drreddys Laboratories | RDY - Ebitda


Drreddys Laboratories reported INR21.59B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Aurora Cannabis CAD 18.48M 3.11M Dec/2025
Bayer EUR 4.45B 2.49B Mar/2026
Canopy Growth CAD -2.87M 19.49M Dec/2025
Cipla INR 12.55B 6.4B Dec/2025
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Drreddys Laboratories INR 21.59B 1.49B Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Novartis USD 5.3B 530M Mar/2026
Pacira USD 40.24M 1.53M Mar/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 90.82M 3.99M Dec/2025
Richter Gedeon HUF 84.16B 8.44B Dec/2024
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
Supernus Pharmaceuticals USD 29.23M 19.27M Mar/2026
Teva Pharmaceutical Industries USD 1.06B 582M Mar/2026